Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ImageneBio, Inc.
| Metric | ImageneBio, Inc. IMAHealthcare |
|---|---|
| Quality Score | 47 / 100 |
| Revenue (latest) | $800,000 |
| Net income (latest) | −$45M |
| Operating margin | −6056.4% |
| Net margin | −5668.6% |
| Return on equity | −34.1% |
| Return on assets | −29.6% |
| Return on capital (ROCE) | −34.2% |
| Debt / equity | 0.15× |
| Revenue growth (YoY) | −77.1% |
| Altman Z″ (distress) | 5.55 |
| Accruals / assets | 1.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.